Abraham Abittan, M.D.
NPI 1962548404 · Specialist · Woodmere, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Abraham Abittan, M.D. is a Specialist provider in Woodmere, NY (NPI 1962548404).
Provider details
- NPI number
- 1962548404
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 187786 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
13,254 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 5,586 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,760 | $96 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 1,582 | $58 |
| Test for Allergy Using Allergenic Extract95004 | 1,056 | $4 |
| Biopsy of Related Skin Growth, First Growth11102 | 679 | $101 |
| Application of Light With Debridement to Destroy Precancer Skin Growth96574 | 484 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 32 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Mupirocin | 244 | 169 |
| Ketoconazole | 215 | 126 |
| Triamcinolone Acetonide | 164 | 110 |
| Mometasone Furoate | 125 | 95 |
| Clobetasol Propionate | 121 | 65 |
| Alclometasone Dipropionate | 103 | 68 |
| Ammonium Lactate | 97 | 61 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,107 across 67 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-01-30
- Last updated
- 2007-07-08
Frequently asked questions
- What is Abraham Abittan's NPI number?
- Abraham Abittan's National Provider Identifier (NPI) is 1962548404, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Abraham Abittan's specialty?
- Abraham Abittan is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Abraham Abittan located?
- Abraham Abittan's practice location on file with NPPES is 1122 Broadway, Woodmere, NY 11598-1242.
- What is Abraham Abittan's phone number?
- The practice phone number listed in the NPPES registry for Abraham Abittan is (516) 295-3838.
- Does Abraham Abittan accept Medicare?
- Abraham Abittan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Abraham Abittan's NPI active?
- Yes — Abraham Abittan's NPI (1962548404) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.